NCT05428501

Brief Summary

ACTION China is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment options or pharmaceutical product. Collection of data will be performed via quantitative online survey by a third-party vendor. The goal of this study is to provide insights to drive awareness around the needs of People Living with Obesity (PLwO) and Health Care Professionals (HCPs) involved in obesity treatment and management.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 19, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 23, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

August 18, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2022

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

3 months

First QC Date

May 19, 2022

Last Update Submit

September 6, 2024

Conditions

Outcome Measures

Primary Outcomes (8)

  • Weight loss motivators

    Multi-selection from defined list

    Day 1-day of survey

  • PLwO / participants who made serious weight loss effort

    Percentage of participants

    Day 1-day of survey

  • Response to/evaluation of weight loss discussion according to predefined list of values

    Single selection from defined list 1. Not at all helpful 2. A little helpful 3. Somewhat helpful 4. Very helpful 5. Extremely helpful

    Day 1-day of survey

  • Effective weight loss methods

    Multi-selection from defined list

    Day 1-day of survey

  • Obesity attitudes

    5-point Likert scales: 1: Do not agree at all 5: Completely agree

    Day 1-day of survey

  • Attitudes toward prescription weight loss medication and surgery

    5-point Likert scales: 1: Do not agree at all 5: Completely agree

    Day 1-day of survey

  • Agreement with predefined Obesity and weight management measures

    5-point Likert scales: 1: Do not agree at all 5: Completely agree

    Day 1-day of survey

  • Degree to which healthcare and society is meeting needs of PLwO

    5-point Likert scales: 1: Not at all meeting the needs 5: Completely meeting the needs

    Day 1-day of survey

Secondary Outcomes (8)

  • Weight loss barriers

    Day 1-day of survey

  • Top factors for improving weight loss outcomes

    Day 1-day of survey

  • Types of weight management goals

    Day 1-day of survey

  • Most helpful information for participants for weight loss

    Day 1-day of survey

  • Responsibility for improving health of PLwO (rank of individuals/organizations in order of their responsibility)

    Day 1-day of survey

  • +3 more secondary outcomes

Study Arms (2)

Person Living with Obesity (PLwO)

PLwO recruited via online platforms or face-to-face channels

Other: no treatment given

Health Care Professionals (HCPs)

HCPs treating people who have obesity

Other: no treatment given

Interventions

People / Person Living with Obesity (PLwO) Health Care Professionals (HCPs)

Health Care Professionals (HCPs)Person Living with Obesity (PLwO)

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The respondent population will include people living with obesity (PLwO) and health care professionals (HCPs) involved in obesity treatment and management

You may qualify if:

  • PLwO:
  • Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
  • Male or female, aged above or equal to 18 years at the time of signing informed consent
  • Lives in mainland China and is native Chinese
  • Current BMI based on self-reported height and weight of at least 28 kg/m\^2 as per mainland China definition of obesity(16) (calculated using an algorithm within the survey instrument)
  • HCPs:
  • Informed consent obtained before any study related activities (study-related activities are any procedure related to recording/collection of data according to the protocol)
  • Male or female, aged greather than or equal to18 years at the time of signing informed consent.
  • Physician with a license to practice
  • Specialty is not surgeon (including general, bariatric or plastic surgeon)
  • Practices in mainland China with at least 5 years in clinical practice
  • Spends at least 50% of time in direct patient care (as opposed to surgical procedures, office procedures or research/administrative tasks)
  • Has seen at least 100 patients in the past month
  • Has seen at least 10 patients needing weight management (defined as a patient with a BMI greather than or equal to28 kg/m\^2 with or without comorbidities) in the past month

You may not qualify if:

  • PLwO
  • \. Previous participation in this study. Participation is defined as having given online consent in this study 2. Currently pregnant 3. Participates in intense fitness or body building programs 4. Has had significant, unintentional weight loss (due to major injury, illness, etc) in the past 6 months 5. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation HCPs
  • Previous participation in this study. Participation is defined as having given informed consent in this study.
  • Unwillingness, inability, or language barriers precluding adequate understanding or cooperation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Novo Nordisk Investigational Site

Beijing, China

Location

Related Publications (2)

  • Ji L, Mu Y, Chang C, Wang H, Zhao D, Liu D, Shen Z, Chen W. Perceptions, attitudes and barriers to effective obesity care among people living with obesity and healthcare professionals in China: The ACTION-China study. Diabetes Obes Metab. 2024 Oct;26(10):4694-4704. doi: 10.1111/dom.15837. Epub 2024 Aug 9.

  • Luo Y, Mu Y, Chen W, Wang H, Zhao D, Liu D, Zhang J, Ji L. Attitudes towards therapeutic options for weight management, including weight loss medications and surgery, among people living with obesity and healthcare professionals in China: A secondary analysis from the ACTION-China study. Diabetes Obes Metab. 2025 Jul;27(7):3627-3634. doi: 10.1111/dom.16369. Epub 2025 Apr 15.

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Clinical Transparency (dept. 2834)

    Novo Nordisk A/S

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 19, 2022

First Posted

June 23, 2022

Study Start

August 18, 2022

Primary Completion

November 30, 2022

Study Completion

November 30, 2022

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

According to the Novo Nordisk disclosure commitment on novonordisk-trials.com

More information

Locations